Table of Content



Introduction
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Overview
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Therapeutics Development
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Therapeutics Assessment
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Companies Involved in Therapeutics Development
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Drug Profiles
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Dormant Projects
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Discontinued Products
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Product Development Milestones
Appendix



List of Figures



Number of Products under Development for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020


List of Tables



Number of Products under Development for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma), H1 2020
Number of Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Aldeyra Therapeutics Inc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Apexian Pharmaceuticals Inc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by AstraZeneca Plc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by BeiGene Ltd, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Bexion Pharmaceuticals LLC, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by BNOAT Oncology Inc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Calithera Biosciences Inc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Epizyme Inc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by F. Hoffmann-La Roche Ltd, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Merck & Co Inc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Millennium Pharmaceuticals Inc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Novartis AG, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Oncomatryx Biopharma SL, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Open Therapeutics LLC, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Pfizer Inc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Plexxikon Inc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Resverlogix Corp, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Sorrento Therapeutics Inc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Vyriad Inc, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Dormant Projects, H1 2020
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Discontinued Products, H1 2020